Publications
5808 Results
- Journal / Conference
- Journal of Urology 190(4):1200-1204;
- Year
- 2013
- Research Committee(s)
- Genitourinary
- PMID
- PMID23597452
- PMC
- PMC4113593
- Study Number(s)
- S0353
SWOG S0353: Phase II trial of intravesical gemcitabine in patients with non-muscle invasive bladder cancer who recurred following at least two prior courses of bacillus Calmette-Guérin
- Journal / Conference
- Journal of Clinical Oncology 31(6):692-700;
- Year
- 2013
- Research Committee(s)
- Lymphoma
- PMID
- PMID23182984
- PMC
- PMC3574267
- Study Number(s)
- E2496
Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced stage classical hodgkin lymphoma
- Journal / Conference
- Journal of Clinical Oncology 31(6):684-691;
- Year
- 2013
- Research Committee(s)
- Lymphoma
- PMID
- PMID23182987
- PMC
- PMC3574266
- Study Number(s)
- E2496
A randomized phase III trial of ABVD vs. Stanford V +/- radiation therapy in locally extensive and advanced stage hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496)
- Journal / Conference
- Cancer 119(23):4170-4179;
- Year
- 2013
- Research Committee(s)
- Leukemia
- PMID
- PMID24104597
- PMC
- PMC3833872
- Study Number(s)
- S0106, SWOG-8600, SWOG-9500
Outcome of adolescents and young adults with acute myeloid leukemia treated on COG trials compared to CALGB and SWOG trials
- Journal / Conference
- Journal of Clinical Oncology 31(20):2627-2633;
- Year
- 2013
- Research Committee(s)
- Symptom Management and Survivorship
- PMID
- PMID23733756
- PMC
- PMC3699727
- Study Number(s)
- S0715
Randomized double-blind placebo-controlled trial of acetyl-l-carnitine for the prevention of taxane induced neuropathy in women undergoing adjuvant breast cancer therapy
- Journal / Conference
- Contemporary Clinical Trials 34(1):1-9;
- Year
- 2013
- Research Committee(s)
- Breast
- PMID
- PMID23000081
- PMC
- PMC3525786
- Study Number(s)
- S1007
Integrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating OncotypeDX-guided management for women with breast cancer involving lymph nodes
- Journal / Conference
- Blood 121(18):3547-3553;
- Year
- 2013
- Research Committee(s)
- Lymphoma
- PMID
- PMID23386127
- PMC
- PMC3643756
- Study Number(s)
- E2496
Plasma Epstein-Barr viral DNA as a marker of tumor response in Hodgkin lymphoma
- Journal / Conference
- Journal of Clinical Oncology 31(5):536-542;
- Year
- 2013
- Research Committee(s)
- Cancer Care Delivery and Outcomes and Comparative Effectiveness
- PMID
- PMID23295802
- PMC
- PMC3565180
Patient income level and cancer clinical trial participation
- Journal / Conference
- British Journal of Haematology 161(1):76-86;
- Year
- 2013
- Research Committee(s)
- Lymphoma
- PMID
- PMID23356491
- PMC
- PMC3906856
- Study Number(s)
- E2496
The efficacy and tolerability of ABVD and Stanford V in older hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496
- Journal / Conference
- Journal of the National Cancer Institute 105(13):954-959;
- Year
- 2013
- Research Committee(s)
- Cancer Care Delivery and Multiple sites
- PMID
- PMID23776198
- PMC
- PMC3699438